INS and type 1 diabetes mellitus: At the end of 1990s, an Edmonton group developed an islet transplantation protocol using the steroid-free immunosuppressive agents sirolimus, daclizumab and tacrolimus, and reported on seven patients with severe type 1 diabetes who were all able to function without insulin treatment with no episodes of hypoglycemic coma [14].